| P2093 | author name string | Shishir K Maithel | |
| | Charles A Staley | |
| | David A Kooby | |
| | Juan M Sarmiento | |
| | Sameer H Patel | |
| P2860 | cites work | Is it useful to detect lymphovascular invasion in lymph node-positive patients with primary operable breast cancer? | Q44660312 |
| | Intrahepatic cholangiocarcinoma: rising frequency, improved survival, and determinants of outcome after resection | Q45424625 |
| | Gemcitabine-based adjuvant chemotherapy improves survival after aggressive surgery for hilar cholangiocarcinoma. | Q46022234 |
| | Surgical treatment of cholangiocarcinoma. | Q50946792 |
| | Adequate Lymph Node Assessment for Extrahepatic Bile Duct Adenocarcinoma | Q57845868 |
| | Intrahepatic Cholangiocarcinoma: An International Multi-Institutional Analysis of Prognostic Factors and Lymph Node Assessment | Q60675548 |
| | A new staging system for mass-forming intrahepatic cholangiocarcinoma: analysis of preoperative and postoperative variables | Q77357297 |
| | Peripheral cholangiocarcinoma: presentation, diagnosis, pathology and management | Q78038799 |
| | Prognostic factors of intrahepatic cholangiocarcinoma after hepatic resection: univariate and multivariate analysis | Q78061902 |
| | AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group | Q83979420 |
| | Surgical treatment of hilar cholangiocarcinoma in a new era: comparison among leading Eastern and Western centers, Leeds | Q84789385 |
| | Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma | Q85191683 |
| | Lymph node metastasis from hilar cholangiocarcinoma: audit of 110 patients who underwent regional and paraaortic node dissection | Q33935808 |
| | Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma | Q33961798 |
| | Chemotherapy for bile duct carcinoma in the light of adjuvant chemotherapy to surgery | Q33986826 |
| | Cholangiocarcinoma. | Q33990595 |
| | Cholangiocarcinoma: modern advances in understanding a deadly old disease | Q34000079 |
| | Intrahepatic cholangiocarcinoma: resectability, recurrence pattern, and outcomes | Q34093557 |
| | Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution | Q34578979 |
| | Clinicopathological and prognostic analysis of 429 patients with intrahepatic cholangiocarcinoma | Q34614931 |
| | Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer | Q34618537 |
| | The epidemiology of cholangiocarcinoma | Q35802314 |
| | The role of gemcitabine in the treatment of cholangiocarcinoma and gallbladder cancer: a systematic review | Q36338095 |
| | Surgical management and prognostic factors of hilar cholangiocarcinoma: experience with 115 cases in China | Q37188747 |
| | Extrahepatic cholangiocarcinoma: a comparison of patients with resected proximal and distal lesions. | Q37316584 |
| | Guidelines for the management of biliary tract and ampullary carcinomas: surgical treatment | Q37478218 |
| | Prognostic relevance of the lymph node ratio in surgical patients with extrahepatic cholangiocarcinoma | Q39814982 |
| | Surgery and chemotherapy for intrahepatic cholangiocarcinoma. | Q41140456 |
| | Lymph node status combined with lymphovascular invasion creates a more powerful tool for predicting outcome in patients with invasive breast cancer | Q44182472 |
| | A proposed staging system for intrahepatic cholangiocarcinoma | Q44370691 |
| | Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection | Q44531650 |
| P433 | issue | 9 | |
| P921 | main subject | cholangiocarcinoma | Q124292 |
| P304 | page(s) | 605-611 | |
| P577 | publication date | 2011-07-26 | |
| P1433 | published in | Hepato Pancreato Biliary | Q15756742 |
| P1476 | title | The prognostic importance of lymphovascular invasion in cholangiocarcinoma above the cystic duct: a new selection criterion for adjuvant therapy? | |
| P478 | volume | 13 | |